EUVIMEDEUVIMED entdecken
Crossref

Propionic acid and neurofilament light chain in multiple sclerosis

Sofia Sandgren, David Leppert iD, Jens Kuhle iD

Brain · 07.07.2026 · 149 (7) · 2187-2188

DOI: 10.1093/brain/awag192 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, online erschienen am 06.07.2026. Verfasst von Sofia Sandgren und 2 weiteren Autor:innen. Beteiligte Einrichtung: Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Department of Neurology, University Hospital and…. Die Arbeit nennt 10 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This scientific commentary refers to ‘Propionic acid in multiple sclerosis: a phase 2b, double blind, randomized placebo-controlled trial’, by Moser et al. (https://doi.org/10.1093/brain/awag099).

Autor:innen und Institutionen

  • Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Department of Neurology, University Hospital and University of Basel, Basel 4031, Switzerland.
  • Department of Biomedicine, University Hospital and University of Basel, Basel 4031, Switzerland.
  • Department of Clinical Research, University Hospital and University of Basel, Basel 4031, Switzerland.

ORCID-Profile: David Leppert, Jens Kuhle

Zitieren

APA

Sandgren, S., Leppert, D., & Kuhle, J. (2026). Propionic acid and neurofilament light chain in multiple sclerosis. Brain, 149(7), 2187-2188. https://doi.org/10.1093/brain/awag192

Vancouver

Sandgren S, Leppert D, Kuhle J. Propionic acid and neurofilament light chain in multiple sclerosis. Brain. 2026;149(7):2187-2188. doi:10.1093/brain/awag192

BibTeX
@article{Sandgren2026,
  author = {Sandgren, Sofia and Leppert, David and Kuhle, Jens},
  title = {Propionic acid and neurofilament light chain in multiple sclerosis},
  journal = {Brain},
  year = {2026},
  volume = {149},
  number = {7},
  pages = {2187--2188},
  doi = {10.1093/brain/awag192}
}
Kostenlos starten →